Title: Evaluation of lipid profile in normotensive and hypertensive type-2 diabetic population in Rajasthan
Authors: Randhir K.Pandey, Suresh Babu Kondaveeti, Manju Pandey, Madhuri Gupta
DOI: https://dx.doi.org/10.18535/jmscr/v7i5.17
Abstract
Background: The present study was aimed to evaluate the lipid abnormalities among type 2 diabetic subjects in hypertension.
Introduction: Diabetes mellitus, a major health concern throughout the world, is often coexisting with obesity, hypertension and dyslipidemia. Several studies have shown that dyslipidemia and hypertension, But interplay among them still to be elucidated.
Material & Methods: The present study includes of 500 type 2 diabetic subject & divided into two groups based on hypertension. Biochemical parameters such as total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol (HDL), and lipoprotein-cholesterol (LDL) were analysed in the department of biochemistry of NIMS medical college. Hypertension was taken according to definition of WHO; as systolic blood pressure (SBP) ≥140 mmHg and diastolic (DBP) ≥90 mmHg.
Result: The hypertensive type 2 diabetic subjects shows more TG levels than the normotensive type 2 diabetic subjects where as serum total cholesterol levels are higher in both the cases of normotensive & hypertensive type 2 diabetes subjects.
Conclusion: It can be concluded that hypertriglyceridemia highly significant in hypertensive type 2 DM.
Keywords: Diabetes mellitus, cholesterol, Hypertriglyceridemia.
References
- Wild S, Roglic G, Green A, Sicree R, King H; Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.
- King H, aubert RE, Herman WH; Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414–1431.
- Alessandra SD, Lucianne RM, Roberta AC, Catia C, Sousa P, Carlos AN, Marilia DBG; Impact of Diabetes on Cardiovascular Disease: An Update. International Journal of Hypertension 2013; p 15.
- Klein R, Klein BEK, Lee KE, Cruickshanks KJ, Moss SE; The incidence of hypertension in insulindependent diabetes. Arch Intern Med 1996; 156:622–627.
- Wannamethee SG, Shaper AG, Lennon L, Richard WM; Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005 165: 2644–2650.
- Adler A I, Irene MS, Neil HA, John SY, David RM, Carole AC, et al.; Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British Medical Journal (BMJ) 2000; 321: 412– 419.
- Lago RM, Singh PP, Nesto, RW; Diabetes and hyprtension. Nature Clinical Practice Endocrinology and Metabolism 2007 3:667.
- Beckman JA, Creager MA, Libby P; Diabetes and atherosclerosis, Epid, Pathophysiology, and management: Review article. Journal of the American Medical Association (JAMA) 2002; 287 (19): 2570-81.
- Rahmouni K, Correia ML, Haynes WG, Mark AL; Obesity-associated hyperte-nsion: new insights into mechanisms. Hypertension 2005; 45(1):9-14.
- Howard BV, Ruotolo G, Robbins DC; Obesity and dyslipidemia. Endocrinol Metab Clin North Am. 2003; 32(4):855-67.
- Norm, RC, Campbell, Richard E, Gilbert, Lawrence AL, Pierre L, et al.; Hypertension in people with type 2 diabetes: update on pharmacologic management. Can Fam Physician 2011; 57:997-1002.
- Lakoski SG, Cushman M, Palmas W, Blumenthal R, D’Agostino J, Herrington DM. The Relationship Between Blood Pressure and C- Reactive Protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2005 Nov 15;46(10):1869-74.
- Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S, et al. Increased C-reactive protein concentration in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens. 2003 Oct;21(10):1841-6.
- Stuveling EM, Bakker SJL, Hillege HL, Burgerhof JGM, de Jong PE, Gans ROB, et al. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension. 2004 Apr;43(4):791-6.
- Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademetriou V, et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am. J. Cardiol. 2005 Oct 1;96(7):946-51.
- Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, et al. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern. Med. 2004 Oct;43(10):919-25.